146 related articles for article (PubMed ID: 3560194)
21. Antitumor activity of a Streptococcus pyogenes preparation (OK-432). I. Sequential effector mechanisms following a single OK-432 injection in F344 rats leading to the rejection of syngeneic MADB106 tumor cells.
Fukui H; Reynolds CW
J Natl Cancer Inst; 1987 Nov; 79(5):1011-7. PubMed ID: 3479632
[TBL] [Abstract][Full Text] [Related]
22. [A double blind study of the evaluation of the optimal dose and its frequency in oral administration of OK-432 (Picibanil) by immunological parameters (the 1st report)].
Shiraishi T; Nio Y; Imai S; Tsubono M; Morimoto H; Tseng CC; Tobe T; Tanaka T; Kitamura O; Sakanashi S
Nihon Gan Chiryo Gakkai Shi; 1990 Apr; 25(4):799-811. PubMed ID: 2196311
[TBL] [Abstract][Full Text] [Related]
23. Intraperitoneal administration of the biological response modifier OK-432 and peritoneal recurrence following gastrectomy.
Tsujitani S; Abe Y; Korenaga D; Saitoh A; Watanabe A; Sugimachi K
Hepatogastroenterology; 1990 Oct; 37(5):498-502. PubMed ID: 2253926
[TBL] [Abstract][Full Text] [Related]
24. Induction of interferon-gamma and tumor necrosis factor in ascites of a patient with ovarian cancer by OK-432.
Mori H; Itoh N; Shiraki S; Tamaya T
Nihon Sanka Fujinka Gakkai Zasshi; 1988 Apr; 40(4):497-8. PubMed ID: 3131464
[No Abstract] [Full Text] [Related]
25. Production of factor(s) that render polymorphonuclear leukocytes cytostatic from spleen cells stimulated with a streptococcal preparation, OK-432.
Kimura S; Inoue T; Yamashita T; Midorikawa Y; Arai S; Sendo F
Cancer Res; 1987 Dec; 47(23):6204-9. PubMed ID: 3315182
[TBL] [Abstract][Full Text] [Related]
26. Streptococcal preparation OK-432 promotes the capacity of dendritic cells (DCs) to prime carcinoembryonic antigen (CEA)-specific cytotoxic T lymphocyte responses induced with genetically modified DCs that express CEA.
Ojima T; Iwahashi M; Nakamura M; Matsuda K; Nakamori M; Ueda K; Naka T; Katsuda M; Miyazawa M; Iida T; Yamaue H
Int J Oncol; 2008 Feb; 32(2):459-66. PubMed ID: 18202769
[TBL] [Abstract][Full Text] [Related]
27. [Intratumor injection of OK-432-stimulated peripheral blood mononuclear cells: a significance of mononuclear cell-producing tumor inhibitory factor induced by OK-432].
Mizoguchi T; Katano M; Yamamoto H; Hisatsugu T
Nihon Geka Gakkai Zasshi; 1987 Jun; 88(6):794. PubMed ID: 3627102
[No Abstract] [Full Text] [Related]
28. Locoregional immunotherapy of malignant ascites by intraperitoneal administration of OK-432 plus IL-2 in gastric cancer patients.
Yamaguchi Y; Satoh Y; Miyahara E; Noma K; Funakoshi M; Takashima I; Sawamura A; Toge T
Anticancer Res; 1995; 15(5B):2201-6. PubMed ID: 8572625
[TBL] [Abstract][Full Text] [Related]
29. Lysis of fresh human tumor cells by autologous peripheral blood lymphocytes and pleural effusion lymphocytes activated by OK432.
Uchida A; Micksche M
J Natl Cancer Inst; 1983 Oct; 71(4):673-80. PubMed ID: 6413742
[TBL] [Abstract][Full Text] [Related]
30. [Management of malignant ascites with a streptococcal preparation, OK-432: induction of growth inhibition factor(s) against tumor cells].
Katano M; Yamamoto H; Hisatsugu T
Nihon Geka Gakkai Zasshi; 1986 Apr; 87(4):471. PubMed ID: 3713694
[No Abstract] [Full Text] [Related]
31. [NK activities in cancer patients--their modification by an immunopotentiator].
Sasanami T; Fujishima A; Moriya Y; Imai K; Yachi A
Gan To Kagaku Ryoho; 1982 Dec; 9(12):2186-92. PubMed ID: 7184392
[TBL] [Abstract][Full Text] [Related]
32. [Partial response of lung metastases from a renal cancer treated with endogenous tumor necrosis factor].
Kato M; Ishiwata D; Kakehi R; Oshima N; Soma G; Mizuno D
Gan To Kagaku Ryoho; 1987 Jul; 14(7):2378-80. PubMed ID: 3606157
[TBL] [Abstract][Full Text] [Related]
33. Essential requirement of toll-like receptor 4 expression on CD11c+ cells for locoregional immunotherapy of malignant ascites using a streptococcal preparation OK-432.
Hironaka K; Yamaguchi Y; Okita R; Okawaki M; Nagamine I
Anticancer Res; 2006; 26(5B):3701-7. PubMed ID: 17094388
[TBL] [Abstract][Full Text] [Related]
34. Blastogenic responses of human lymphocytes to a streptococcal preparation OK-432 and its fractions.
Tanaka T; Kaneko Y; Haba F; Katsuta S; Tsutsui K; Tamaki S; Chen DR; Suzuki S; Ueda R; Yamamoto A
J Clin Lab Immunol; 1989 Feb; 28(2):91-6. PubMed ID: 2787407
[TBL] [Abstract][Full Text] [Related]
35. Antitumor effect of OK-432-derived DNA: one of the active constituents of OK-432, a streptococcal immunotherapeutic agent.
Oshikawa T; Okamoto M; Tano T; Sasai A; Kan S; Moriya Y; Ryoma Y; Saito M; Akira S; Sato M
J Immunother; 2006; 29(2):143-50. PubMed ID: 16531815
[TBL] [Abstract][Full Text] [Related]
36. Release of tumor necrosis factor (TNF) into mouse peritoneal fluids by OK-432, a streptococcal preparation.
Yamamoto A; Nagamuta M; Usami H; Sugawara Y; Watanabe N; Niitsu Y; Urushizaki I
Immunopharmacology; 1986 Apr; 11(2):79-86. PubMed ID: 3710767
[TBL] [Abstract][Full Text] [Related]
37. Augmentation by OK-432 of generation of culture-induced killer cells.
Ujiie T
Jpn J Exp Med; 1987 Jun; 57(3):153-61. PubMed ID: 3682231
[TBL] [Abstract][Full Text] [Related]
38. Activation of cytotoxic polymorphonuclear leukocytes by in vivo administration of a streptococcal preparation, OK-432.
Watabe S; Sendo F; Kimura S; Arai S
J Natl Cancer Inst; 1984 Jun; 72(6):1365-70. PubMed ID: 6587156
[TBL] [Abstract][Full Text] [Related]
39. In vitro potentiation of human natural killer cell activity by a streptococcal preparation, OK-432: interferon and interleukin-2 participation in the stimulation with OK-432.
Wakasugi H; Kasahara T; Minato N; Hamuro J; Miyata M; Morioka Y
J Natl Cancer Inst; 1982 Oct; 69(4):807-12. PubMed ID: 6181282
[TBL] [Abstract][Full Text] [Related]
40. Cytotoxic cells induced in tumor-bearing rats by a streptococcus preparation (OK-432).
Hojo H; Hashimoto Y
Gan; 1981 Oct; 72(5):692-9. PubMed ID: 7327369
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
